Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kintor Pharmaceutical Ltd ( (HK:9939) ) has issued an update.
Kintor Pharmaceutical Limited has announced a top-up placing of existing shares and a subscription of new shares under a general mandate. The company plans to sell 20,673,000 shares at HK$2.08 per share, representing approximately 4.62% of its issued share capital. The net proceeds from this subscription, estimated at HK$40.34 million, will be used for general working capital and operations, potentially strengthening the company’s financial position and supporting its ongoing business activities.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited is an investment holding company primarily engaged in the research and development of innovative medicine products and the sales of functional cosmetic products.
Average Trading Volume: 5,233,048
Technical Sentiment Signal: Buy
Current Market Cap: HK$1.21B
For an in-depth examination of 9939 stock, go to TipRanks’ Overview page.